These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30224498)

  • 1. Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures.
    Moore YE; Deeb TZ; Chadchankar H; Brandon NJ; Moss SJ
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10166-10171. PubMed ID: 30224498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCC2 activity is critical in limiting the onset and severity of status epilepticus.
    Silayeva L; Deeb TZ; Hines RM; Kelley MR; Munoz MB; Lee HH; Brandon NJ; Dunlop J; Maguire J; Davies PA; Moss SJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3523-8. PubMed ID: 25733865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally Reducing KCC2 Activity in the Hippocampus is Sufficient to Induce Temporal Lobe Epilepsy.
    Kelley MR; Cardarelli RA; Smalley JL; Ollerhead TA; Andrew PM; Brandon NJ; Deeb TZ; Moss SJ
    EBioMedicine; 2018 Jun; 32():62-71. PubMed ID: 29884458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNK1-regulated inhibitory phosphorylation of the KCC2 cotransporter maintains the depolarizing action of GABA in immature neurons.
    Friedel P; Kahle KT; Zhang J; Hertz N; Pisella LI; Buhler E; Schaller F; Duan J; Khanna AR; Bishop PN; Shokat KM; Medina I
    Sci Signal; 2015 Jun; 8(383):ra65. PubMed ID: 26126716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal K
    McMoneagle E; Zhou J; Zhang S; Huang W; Josiah SS; Ding K; Wang Y; Zhang J
    Acta Pharmacol Sin; 2024 Jan; 45(1):1-22. PubMed ID: 37704745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCC2, epileptiform synchronization, and epileptic disorders.
    Di Cristo G; Awad PN; Hamidi S; Avoli M
    Prog Neurobiol; 2018 Mar; 162():1-16. PubMed ID: 29197650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in mice.
    Jarvis R; Josephine Ng SF; Nathanson AJ; Cardarelli RA; Abiraman K; Wade F; Evans-Strong A; Fernandez-Campa MP; Deeb TZ; Smalley JL; Jamier T; Gurrell IK; McWilliams L; Kawatkar A; Conway LC; Wang Q; Burli RW; Brandon NJ; Chessell IP; Goldman AJ; Maguire JL; Moss SJ
    Cell Rep Med; 2023 Mar; 4(3):100957. PubMed ID: 36889319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizing Control of KCC2: A New Therapeutic Target for Epilepsy.
    Moore YE; Kelley MR; Brandon NJ; Deeb TZ; Moss SJ
    Trends Neurosci; 2017 Sep; 40(9):555-571. PubMed ID: 28803659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCC2 Regulates Neuronal Excitability and Hippocampal Activity via Interaction with Task-3 Channels.
    Goutierre M; Al Awabdh S; Donneger F; François E; Gomez-Dominguez D; Irinopoulou T; Menendez de la Prida L; Poncer JC
    Cell Rep; 2019 Jul; 28(1):91-103.e7. PubMed ID: 31269453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cation-chloride cotransporters and GABA-ergic innervation in the human epileptic hippocampus.
    Muñoz A; Méndez P; DeFelipe J; Alvarez-Leefmans FJ
    Epilepsia; 2007 Apr; 48(4):663-73. PubMed ID: 17319917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and neurochemical substrates of the audiogenic seizure strains: The GASH:Sal model.
    Prieto-Martín AI; Aroca-Aguilar JD; Sánchez-Sánchez F; Muñoz LJ; López DE; Escribano J; de Cabo C
    Epilepsy Behav; 2017 Jun; 71(Pt B):218-225. PubMed ID: 26071997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
    MacKenzie G; O'Toole KK; Moss SJ; Maguire J
    Epilepsy Res; 2016 Oct; 126():185-96. PubMed ID: 27513374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCC2 is required for the survival of mature neurons but not for their development.
    Kontou G; Josephine Ng SF; Cardarelli RA; Howden JH; Choi C; Ren Q; Rodriguez Santos MA; Bope CE; Dengler JS; Kelley MR; Davies PA; Kittler JT; Brandon NJ; Moss SJ; Smalley JL
    J Biol Chem; 2021; 296():100364. PubMed ID: 33539918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could tuning of the inhibitory tone involve graded changes in neuronal chloride transport?
    Titz S; Sammler EM; Hormuzdi SG
    Neuropharmacology; 2015 Aug; 95():321-31. PubMed ID: 25843644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy.
    Campbell SL; Robel S; Cuddapah VA; Robert S; Buckingham SC; Kahle KT; Sontheimer H
    Glia; 2015 Jan; 63(1):23-36. PubMed ID: 25066727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The KCC2 Cotransporter and Human Epilepsy: Getting Excited About Inhibition.
    Kahle KT; Khanna AR; Duan J; Staley KJ; Delpire E; Poduri A
    Neuroscientist; 2016 Dec; 22(6):555-562. PubMed ID: 27130838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCC2 Chloride Transport Contributes to the Termination of Ictal Epileptiform Activity.
    Dzhala VI; Staley KJ
    eNeuro; 2021; 8(2):. PubMed ID: 33239270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromising KCC2 transporter activity enhances the development of continuous seizure activity.
    Kelley MR; Deeb TZ; Brandon NJ; Dunlop J; Davies PA; Moss SJ
    Neuropharmacology; 2016 Sep; 108():103-10. PubMed ID: 27108931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global transgenic upregulation of KCC2 confers enhanced diazepam efficacy in treating sustained seizures.
    Cheung DL; Cooke MJ; Goulton CS; Chaichim C; Cheung LF; Khoshaba A; Nabekura J; Moorhouse AJ
    Epilepsia; 2022 Jan; 63(1):e15-e22. PubMed ID: 34791657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex.
    Conti L; Palma E; Roseti C; Lauro C; Cipriani R; de Groot M; Aronica E; Limatola C
    Epilepsia; 2011 Sep; 52(9):1635-44. PubMed ID: 21635237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.